Value of Urinary Ceruloplasmin as a Marker in Juvenile SLE | ||||
The Egyptian Journal of Pediatric Allergy and Immunology | ||||
Article 2, Volume 20, Issue 1, April 2022, Page 3-6 PDF (529.87 K) | ||||
Document Type: Review | ||||
DOI: 10.21608/ejpa.2022.231501 | ||||
View on SCiNiTO | ||||
Authors | ||||
Elham Hossny 1; Mohammad Sharaf2; Nancy Wahba3; Abdulrahman Warsame4 | ||||
1Pediatric Allergy, Immunology and Rheumatology Unit, Children’s Hospital, Ain Shams University; | ||||
2Pediatric Nephrology Unit, Children’s Hospital, Ain Shams University; | ||||
3Department of Clinical Pathology, Ain Shams University | ||||
4Public Health Hospital, Benadir, Somalia | ||||
Abstract | ||||
Abstract There is substantial evidence that lupus nephritis (LN) is primarily related to type-III hypersensitivity reactions leading to immune complex deposition at the mesangial, subendothelial, and/or subepithelial space near the renal glomerular basement membrane. The search for a non-invasive urinary marker of lupus nephritis is an appealing point of research. There are few studies that have evaluated the role of urinary ceruloplasmin (CP) as a biomarker for LN. Being expressed at high levels by parietal epithelial cells of Bowman’s capsule it could possibly detoxify molecules as they pass through the glomerular filter. CP is a highly effective antioxidant that can prevent oxidative damage to lipids, DNA, and proteins. However, it is unlikely that a single biomarker can replace clinical parameters to monitor disease progression and detect early renal flares. | ||||
Keywords | ||||
Juvenile SLE; urinary ceruloplasmin | ||||
Statistics Article View: 282 PDF Download: 209 |
||||